-
261
Nonclinical Similarity of the Biosimilar Candidate ABP 938 with Aflibercept Reference Product
Published 2024-11-01“…No antibody-dependent cellular cytotoxicity, antibody-dependent cellular phagocytosis, or complement-dependent cytotoxicity was observed with ABP 938 and aflibercept RP. …”
Get full text
Article -
262
Amorphous calcium phosphate-coated surfaces as a model for bone microenvironment in prostate cancer
Published 2025-02-01Get full text
Article -
263
Induction of Cell Activation Processes by Low Frequency Electromagnetic Fields
Published 2004-01-01“…To demonstrate a possible interaction between EMF and cellular systems, we present a mechanistic model describing cell activation as a major importance for cellular response.…”
Get full text
Article -
264
Histone Arginine Methylation-Mediated Epigenetic Regulation of Discoidin Domain Receptor 2 Controls the Senescence of Human Bone Marrow Mesenchymal Stem Cells
Published 2019-01-01“…The application of human bone marrow mesenchymal stem cells (hBM-MSCs) in cell-based clinical therapies is hindered by the limited number of cells remaining after the initial isolation process and by cellular senescence following in vitro expansion. Understanding the process of in vitro senescence in hBM-MSCs would enable the development of strategies to maintain their vitality after cell culture. …”
Get full text
Article -
265
Parkinson’s Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson’s Disease, If Anything?
Published 2012-01-01“…Technologies allowing for the derivation of patient-specific neurons from somatic cells are emerging as powerful in vitro tools to investigate the intrinsic cellular pathological behaviours of the diseases that affect these patients. …”
Get full text
Article -
266
Engineering a membrane protein chaperone to ameliorate the proteotoxicity of mutant huntingtin
Published 2025-01-01“…These variants effectively delay mHttex1 aggregation in vitro and in cellular HD models. The mutated hydrophobic residue in the α4 helix of hsPEX19 variants binds to the N17 domain of mHttex1, thereby inhibiting the initial aggregation process. …”
Get full text
Article -
267
-
268
Phytomedicine nanoformulations for Parkinson's disease
Published 2025-02-01“…Results: The review identified 26 nanoformulations from seven distinct herbal molecules and eight different whole plant extracts that have been evaluated for their effectiveness in treating PD and other brain disorders. In vitro studies demonstrated enhanced cellular uptake and neuroprotective effects, while in vivo models showed improved pharmacokinetics, BBB permeability and neuroprotective outcomes. …”
Get full text
Article -
269
Encapsulated human islets in alginate fiber maintain long-term functionality
Published 2024-03-01Get full text
Article -
270
Optical control of sphingolipid biosynthesis using photoswitchable sphingosines
Published 2025-01-01“…Sphingolipid metabolism comprises a complex interconnected web of enzymes, metabolites, and modes of regulation that influence a wide range of cellular and physiological processes. Deciphering the biological relevance of this network is challenging as numerous intermediates of sphingolipid metabolism are short-lived molecules with often opposing biological activities. …”
Get full text
Article -
271
Preclinical evaluation of avutometinib and defactinib in high‐grade endometrioid endometrial cancer
Published 2024-09-01Get full text
Article -
272
The differentiation state of small intestinal organoid models influences prediction of drug-induced toxicity
Published 2025-01-01“…In vivo, there are proliferative and differentiated cell types critical to maintaining intestinal homeostasis. Traditional in vitro models using transformed cell lines do not capture this cellular complexity, and often fail to predict intestinal toxicity. …”
Get full text
Article -
273
Differences in phenotypes of normal and malignant cells concerning chromosomal fragility and ganglioside expression
Published 2025-02-01“…The average titers of gangliosides and of anti-ganglioside antibodies in extracts from experimental in vitro models of laboratory-incubated cultures of mouse embryonic 3T3 fibroblasts, of mouse malignant myeloma cells, as well as of mixed cultures of both cellular types, were determined after previous passing of each one through GSH-agarose columns about the “selection” of the molecules in each one of the described samples, possessing affinity to GSH. …”
Get full text
Article -
274
-
275
Enhancing Mesenchymal Stromal Cell Immunomodulation for Treating Conditions Influenced by the Immune System
Published 2019-01-01“…However, in 2006, a minimal set of standard criteria has been issued by the International Society of Cellular Therapy for defining derived MSCs. These include adherence to plastic in conventional culture conditions, particular phenotype, and multilineage differentiation capacity in vitro. …”
Get full text
Article -
276
Positively charged specificity site in cyclin B1 is essential for mitotic fidelity
Published 2025-01-01Get full text
Article -
277
Construction of functional tissue-engineered microvasculatures using circulating fibrocytes as mural cells
Published 2025-01-01“…However, a key challenge of microvascular tissue engineering is identifying a cellular source for mural cells. We showed that in vitro , circulating fibrocytes (CFs) can (1) shear and stabilize the microvasculatures formed by vascular endothelial cells (VECs) in a collagen gel, (2) form gap junctions with VECs and (3) induce basement membrane formation. …”
Get full text
Article -
278
Polystyrene microplastics disrupt adrenal steroid synthesis in male mice via mitochondrial dysfunction
Published 2025-01-01“…In vitro, these occurrences coincided with an elevated rate of cell apoptosis observed in adrenocortical cells following exposure to PS-MPs. …”
Get full text
Article -
279
Requirement of Innate Immunity in Tumor-Bearing Mice Cured by Adoptive Immunotherapy Using Tumor-Draining Lymph Nodes
Published 2015-01-01“…The purpose of this study was to determine the cellular effectors of both the adoptively transferred cells and the tumor-bearing host that participate in the antitumor response to adoptive immunotherapy using culture-activated tumor-draining lymph nodes (TDLNs). …”
Get full text
Article -
280